V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330006249 | 330003050 | 1.51 | 0 | Curative (C) | 2015-07-16 | 2015-07-18 | Cisplatin + Radiotherapy | 02 | Y | 330000523 | CISPLATIN + RT |
| 330006250 | 330007624 | 1.82 | 69 | Curative (C) | 2015-04-24 | 2015-04-25 | Cisplatin + Radiotherapy | null | null | 330000539 | CISPLATIN + RT |
| 330006251 | 330003051 | null | 114 | Disease modification (D) | 2013-06-27 | 2013-08-17 | EW Rel rEECur Gemcitabine/Docetaxel | 02 | N | 330000539 | NOT MATCHED |
| 330006252 | 330003054 | 1.73 | 85 | Adjuvant (A) | 2016-10-15 | 2016-10-30 | CISPLATIN + RT | 02 | Y | 330000549 | CISPLATIN + RT |
| 330006253 | 330003055 | 1.59 | 55.4 | Curative (C) | 2018-02-27 | 2018-03-04 | Cisplatin 100 + RT(H&N) 1 day | null | null | 330000575 | CISPLATIN + RT |
| 330006254 | 330003055 | 0.87 | 15.8 | Curative (C) | 2014-11-22 | 2014-11-23 | NB HRNBL-1 Isotretinoin | 02 | null | 330000575 | NOT MATCHED |
| 330006255 | 330003055 | 0 | 29.7 | null | 2015-07-19 | 2015-08-23 | BMT Fludarabine/Thiotepa/Treosulfan + ATG | null | N | 330000575 | NOT MATCHED |
| 330006256 | 330003057 | null | 73 | Palliative (P) | 2017-01-25 | 2017-01-26 | NB HRNBL-1 BUMEL MAT | N | null | 330000589 | NOT MATCHED |
| 330006257 | 330003059 | 1.73 | 84 | Adjuvant (A) | 2017-04-23 | 2017-05-17 | Cisplatin 100 + RT(H&N) 1 day | N | N | 330000591 | CISPLATIN + RT |
| 330006259 | 330003061 | 1.6 | 82.5 | Curative (C) | 2017-09-20 | 2017-09-26 | Cisplatin + Radiotherapy | null | null | 330000597 | CISPLATIN + RT |
| 330006260 | 330003062 | 1 | 88.8 | Neo-adjuvant (N) | 2014-01-27 | 2014-01-30 | CNS ATRT Doxorubicin + GCSF | N | N | 330000620 | NOT MATCHED |
| 330006261 | 330010160 | 1.59 | null | Curative (C) | 2016-05-20 | 2016-06-19 | Cisplatin 100 + RT(H&N) 1 day | N | null | 330000622 | CISPLATIN + RT |
| 330006262 | 330003063 | null | 57 | Curative (C) | 2016-10-28 | 2016-12-16 | Cisplatin 100 + RT(H&N) 1 day | 2 | Y | 330000628 | CISPLATIN + RT |
| 330006263 | 330007631 | 1.86 | null | Curative (C) | 2016-07-26 | 2016-10-01 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 330000629 | CISPLATIN + RT |
| 330006264 | 330003064 | null | 76 | Not known (9) | 2017-08-17 | 2017-08-17 | Cisplatin + Radiotherapy | N | N | 330000642 | CISPLATIN + RT |
| 330006265 | 330003068 | null | 103.3 | Curative (C) | 2015-03-25 | 2015-07-23 | EW Rel rEECur Topotecan/Cyclophosphamide | N | Y | 330000643 | NOT MATCHED |
| 330006266 | 330007634 | 1.75 | 80.5 | Adjuvant (A) | 2015-04-01 | 2015-04-21 | Cisplatin + Radiotherapy | 02 | null | 330000645 | CISPLATIN + RT |
| 330006267 | 330007634 | null | 85 | Curative (C) | 2016-04-10 | 2016-04-11 | Cisplatin + Radiotherapy | 02 | N | 330000645 | CISPLATIN + RT |
| 330006268 | 330003072 | 0 | 17 | Neo-adjuvant (N) | 2017-06-13 | 2017-06-13 | Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE | 02 | N | 330000651 | NOT MATCHED |
| 330006269 | 330007637 | 1.8 | null | Curative (C) | 2014-01-29 | 2014-02-16 | CISPLATIN + RT | 2 | Y | 330000665 | CISPLATIN + RT |
| 330006270 | 330003075 | 1.8 | 99.7 | Curative (C) | 2015-03-16 | 2015-03-23 | Cisplatin + Radiotherapy | 02 | Y | 330000666 | CISPLATIN + RT |
| 330006271 | 330003075 | 1.65 | 91.2 | Curative (C) | 2017-10-20 | 2017-11-15 | CISPLATIN + RT | N | null | 330000666 | CISPLATIN + RT |
| 330006272 | 330003077 | 1.58 | 62 | Curative (C) | 2017-11-05 | 2017-12-10 | Cisplatin + Radiotherapy | 02 | N | 330000674 | CISPLATIN + RT |
| 330006273 | 330003077 | 1.73 | 84.9 | Curative (C) | 2015-03-31 | 2015-09-14 | Cisplatin + Radiotherapy | 2 | null | 330000674 | CISPLATIN + RT |
| 330006274 | 330003077 | 1.51 | 81.8 | Curative (C) | null | 2015-02-17 | Cisplatin 100 + RT(H&N) 1 day | null | null | 330000674 | CISPLATIN + RT |
| 330006275 | 330003078 | 0 | 8.5 | Curative (C) | 2015-03-28 | 2015-03-28 | CYTARABINE + FLUDARABINE + IDARUBICIN + PEGASPARAGINASE | 1 | Y | 330000684 | NOT MATCHED |
| 330006276 | 330003080 | null | 91.9 | Curative (C) | null | 2014-02-02 | CISPLATIN + RT | N | Y | 330000685 | CISPLATIN + RT |
| 330006277 | 330003080 | 0 | 13.8 | Neo-adjuvant (N) | 2015-09-23 | 2015-09-30 | WT SIOP 2002 01 post op Carbo, Etop | 2 | N | 330000685 | NOT MATCHED |
| 330006278 | 330003082 | null | 55.5 | Curative (C) | 2016-04-09 | 2016-04-15 | Cisplatin + Radiotherapy | 2 | null | 330000709 | CISPLATIN + RT |
| 330006279 | 330003083 | 1.65 | 58.2 | Adjuvant (A) | 2013-12-08 | 2014-01-02 | Cisplatin 100 + RT(H&N) 1 day | N | N | 330000710 | CISPLATIN + RT |
| 330006280 | 330003083 | null | null | Disease modification (D) | 2017-02-11 | 2017-05-16 | Cisplatin + Radiotherapy | 2 | Y | 330000710 | CISPLATIN + RT |
| 330006281 | 330003084 | 0 | 7 | null | 2017-07-12 | 2017-07-14 | LCHIV Cont A | null | null | 330000715 | NOT MATCHED |
| 330006282 | 330003084 | null | 90.6 | Disease modification (D) | 2014-11-05 | 2014-11-30 | CISPLATIN + RT | 02 | N | 330000715 | CISPLATIN + RT |
| 330006283 | 330003085 | null | 88.4 | Adjuvant (A) | 2016-09-13 | 2016-10-22 | Cisplatin + Radiotherapy | 02 | N | 330000719 | CISPLATIN + RT |
| 330006284 | 330003085 | 1.82 | null | Adjuvant (A) | 2013-09-27 | 2013-09-27 | Cisplatin 100 + RT(H&N) 1 day | 02 | null | 330000719 | CISPLATIN + RT |
| 330006285 | 330003086 | 1.8 | 71 | Curative (C) | 2017-11-02 | 2017-11-12 | Cisplatin + Radiotherapy | 2 | null | 330000742 | CISPLATIN + RT |
| 330006286 | 330003087 | null | 80.95 | Adjuvant (A) | 2014-01-22 | 2014-01-28 | Cisplatin + Radiotherapy | N | Y | 330000761 | CISPLATIN + RT |
| 330006287 | 330003088 | null | 66.75 | Neo-adjuvant (N) | 2014-12-17 | 2014-12-26 | Cisplatin 100 + RT(H&N) 1 day | 02 | null | 330000767 | CISPLATIN + RT |
| 330006288 | 330003088 | 1.43 | 114 | Neo-adjuvant (N) | 2016-07-31 | 2016-07-31 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + METHOTREXATE + VINCRISTINE | 02 | N | 330000767 | NOT MATCHED |
| 330006289 | 330003089 | 0 | null | Disease modification (D) | 2015-05-02 | 2015-05-05 | NB HRNBL-1 TVD | null | N | 330000773 | NOT MATCHED |
| 330006290 | 330003089 | null | 8.5 | Curative (C) | null | 2017-05-31 | EW EuroEwing 2012 Arm A VAC | N | N | 330000773 | NOT MATCHED |
| 330006291 | 330003091 | 1.35 | 73 | Neo-adjuvant (N) | 2014-07-03 | 2014-07-09 | EW Rel rEECur Topotecan/Cyclophosphamide | 02 | N | 330000779 | NOT MATCHED |
| 330006292 | 330003091 | 1.71 | 55.1 | Curative (C) | 2017-03-24 | 2017-04-13 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330000779 | CISPLATIN + RT |
| 330006293 | 330003092 | null | 19.2 | Curative (C) | 2015-02-07 | 2015-02-28 | NB Rel GD2ch14.18/CHO, IL-2 Isotret | N | N | 330000793 | NOT MATCHED |
| 330006294 | 330003094 | 1.67 | 65.3 | null | 2016-05-07 | 2016-05-07 | Cisplatin + Radiotherapy | 02 | Y | 330000793 | CISPLATIN + RT |
| 330006295 | 330003094 | null | 82 | Curative (C) | 2016-09-23 | 2016-09-24 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330000793 | CISPLATIN + RT |
| 330006296 | 330003095 | 1.69 | 14.2 | Curative (C) | 2014-05-11 | 2014-06-04 | NB HRNBL-1 Isotretinoin | N | N | 330000827 | NOT MATCHED |
| 330006297 | 330003095 | null | null | Radical (R) | null | 2017-07-28 | CISPLATIN + RT | N | Y | 330000827 | CISPLATIN + RT |
| 330006298 | 330003096 | 1.7 | null | Curative (C) | 2015-12-12 | 2015-12-14 | Cisplatin + Radiotherapy | null | Y | 330000839 | CISPLATIN + RT |
| 330006299 | 330003097 | 1.72 | 72 | Radical (R) | 2015-06-08 | 2015-06-12 | CISPLATIN + RT | N | Y | 330000847 | CISPLATIN + RT |